This post was originally published on The Asian Age | Home.
Bharat Biotech’s Covaxin trials suspended in Brazil after graft allegations
Bharat Biotech had on Friday announced cancellation of the MoU it signed for its COVID-19 vaccine Covaxin for the Brazilian market